Adverse Reaction Signals Mining of Vonoprazan: A Pharmacovigilance Study Based on FAERS

Table 3

Basic information of AE report.

	n	(%)
Gender
Male	1392	53.64
Female	1028	39.61
Missing	175	6.74
Total	2595	100.00
Age
<18	12	0.46
18–64	745	28.71
≥65	1592	61.35
Missing	246	9.48
Total	2595	100.00
Reporting year
2022	1077	41.50
2021	506	19.50
2020	217	8.36
2019	343	13.22
2018	247	9.52
2017	159	6.13
2016	45	1.73
2015	1	0.04
Total	2595	100.00
Reported person
Physician	1656	63.82
Pharmacist	418	16.11
Consumer	214	8.25
Health-professional	191	7.36
Other health-professional	93	3.58
Missing	23	0.89
Total	2595	100.00
Outcome
Hospitalization	1639	39.59
Other serious important medical events	1543	37.27
Death	558	13.48
Life-threatening	301	7.27
Disability	99	2.39
Total	4140	100.00